Abstract
Metformin and sulfonylureas, used for Type 2 Diabetes Mellitus (T2DM) have been associated with electrolyte and acid-base imbalances. These imbalances can result in complications such as hyperkalemia and cardiac impairments which are particularly problematic for colorectal cancer patients (CRC). We aim to quantify the risk for electrolyte and acid-base imbalances associated with metformin vs sulfonylurea use in elderly CRC patients with T2DM, where the question remains unexamined.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
Paper Title
Journal
Date
